NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan)
Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan)

NCT01773993

CompletedN/A

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Conditions: Pain Associated With Fibromyalgia

Interventions: Pregabalin

To collect the efficacy and safety information of Pregabalin on Fibromyalgia patients related to their appropriate use in daily practice.

Eligibility overview

Sex: ALL

Age: 0 Years to

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Clinical diagnosis of Fibromyalgia
* Pregabalin naive patient

Exclusion Criteria:

* Clinical diagnosis of neuropathic pain